66 related articles for article (PubMed ID: 24526736)
21. MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53.
Fukaya R; Ohta S; Yaguchi T; Matsuzaki Y; Sugihara E; Okano H; Saya H; Kawakami Y; Kawase T; Yoshida K; Toda M
Cancer Res; 2016 May; 76(9):2813-23. PubMed ID: 26980763
[TBL] [Abstract][Full Text] [Related]
22. Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer.
Holzer K; Drucker E; Roessler S; Dauch D; Heinzmann F; Waldburger N; Eiteneuer EM; Herpel E; Breuhahn K; Zender L; Schirmacher P; Ori A; Singer S
Am J Pathol; 2017 Feb; 187(2):228-235. PubMed ID: 27939741
[TBL] [Abstract][Full Text] [Related]
23. p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6.
Phalke S; Mzoughi S; Bezzi M; Jennifer N; Mok WC; Low DH; Thike AA; Kuznetsov VA; Tan PH; Voorhoeve PM; Guccione E
Nucleic Acids Res; 2012 Oct; 40(19):9534-42. PubMed ID: 22987071
[TBL] [Abstract][Full Text] [Related]
24. Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer.
Wang X; Ruan Y; Wang X; Zhao W; Jiang Q; Jiang C; Zhao Y; Xu Y; Sun F; Zhu Y; Xia S; Xu D
Cell Prolif; 2017 Apr; 50(2):. PubMed ID: 27976428
[TBL] [Abstract][Full Text] [Related]
25. Detection of p53 protein transcriptional activity by chromatin immunoprecipitation.
Yang-Hartwich Y; Romanoff E; Bingham J; Alvero AB; Mor G
Methods Mol Biol; 2015; 1219():87-93. PubMed ID: 25308264
[TBL] [Abstract][Full Text] [Related]
26. G protein subunit α q regulates gastric cancer growth via the p53/p21 and MEK/ERK pathways.
Wang Y; Xiao H; Wu H; Yao C; He H; Wang C; Li W
Oncol Rep; 2017 Apr; 37(4):1998-2006. PubMed ID: 28350126
[TBL] [Abstract][Full Text] [Related]
27. Activation of p53 by MEG3 non-coding RNA.
Zhou Y; Zhong Y; Wang Y; Zhang X; Batista DL; Gejman R; Ansell PJ; Zhao J; Weng C; Klibanski A
J Biol Chem; 2007 Aug; 282(34):24731-42. PubMed ID: 17569660
[TBL] [Abstract][Full Text] [Related]
28. Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage.
Taira N; Yamaguchi T; Kimura J; Lu ZG; Fukuda S; Higashiyama S; Ono M; Yoshida K
Proc Natl Acad Sci U S A; 2014 Jan; 111(2):717-22. PubMed ID: 24379358
[TBL] [Abstract][Full Text] [Related]
29. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M
Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148
[TBL] [Abstract][Full Text] [Related]
30. Rap2b, a novel p53 target, regulates p53-mediated pro-survival function.
Zhang X; He Y; Lee KH; Dubois W; Li Z; Wu X; Kovalchuk A; Zhang W; Huang J
Cell Cycle; 2013 Apr; 12(8):1279-91. PubMed ID: 23535297
[TBL] [Abstract][Full Text] [Related]
31. Identification of UNC5A as a novel transcriptional target of tumor suppressor p53 and a regulator of apoptosis.
Miyamoto Y; Futamura M; Kitamura N; Nakamura Y; Baba H; Arakawa H
Int J Oncol; 2010 May; 36(5):1253-60. PubMed ID: 20372800
[TBL] [Abstract][Full Text] [Related]
32. Dual localization of human DNA topoisomerase IIIalpha to mitochondria and nucleus.
Wang Y; Lyu YL; Wang JC
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12114-9. PubMed ID: 12209014
[TBL] [Abstract][Full Text] [Related]
33. Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V(D)J recombination.
Rashkovan M; Vadnais C; Ross J; Gigoux M; Suh WK; Gu W; Kosan C; Möröy T
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5411-9. PubMed ID: 25468973
[TBL] [Abstract][Full Text] [Related]
34. p53 suppresses CCL2-induced subcutaneous tumor xenograft.
Tang X; Amar S
Tumour Biol; 2015 Apr; 36(4):2801-8. PubMed ID: 25492482
[TBL] [Abstract][Full Text] [Related]
35. p53 stimulates human topoisomerase I activity by modulating its DNA binding.
Søe K; Grosse F
Nucleic Acids Res; 2003 Nov; 31(22):6585-92. PubMed ID: 14602918
[TBL] [Abstract][Full Text] [Related]
36. p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN.
Ohashi T; Idogawa M; Sasaki Y; Tokino T
Cancer Lett; 2017 Apr; 390():58-66. PubMed ID: 28093207
[TBL] [Abstract][Full Text] [Related]
37. DNA repair processes are critical mediators of p53-dependent tumor suppression.
Janic A; Valente LJ; Wakefield MJ; Di Stefano L; Milla L; Wilcox S; Yang H; Tai L; Vandenberg CJ; Kueh AJ; Mizutani S; Brennan MS; Schenk RL; Lindqvist LM; Papenfuss AT; O'Connor L; Strasser A; Herold MJ
Nat Med; 2018 Jul; 24(7):947-953. PubMed ID: 29892060
[TBL] [Abstract][Full Text] [Related]
38. Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes.
Al-Ansari MM; Aboussekhra A
PLoS One; 2014; 9(3):e90907. PubMed ID: 24595168
[TBL] [Abstract][Full Text] [Related]
39. FATS is a transcriptional target of p53 and associated with antitumor activity.
Zhang X; Zhang Q; Zhang J; Qiu L; Yan SS; Feng J; Sun Y; Huang X; Lu KH; Li Z
Mol Cancer; 2010 Sep; 9():244. PubMed ID: 20843368
[TBL] [Abstract][Full Text] [Related]
40. APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner.
Yi Y; Tsai SH; Cheng JC; Wang EY; Anglesio MS; Cochrane DR; Fuller M; Gibb EA; Wei W; Huntsman DG; Karsan A; Hoodless PA
Gynecol Oncol; 2017 Dec; 147(3):663-671. PubMed ID: 29079036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
